Phase 2B COPD Trial to Use Point-of-Care Test for Rhinovirus Detection
The phase 2B trial of vapendavir will use bioMérieux’s Biofire Spotfire panel—a CLIA-waived molecular test that detects rhinovirus—to confirm infections in COPD patients.
Latest Articles
Editor's Top Picks
Clinical Labs Navigate What’s Next After FDA’s LDT Rule Reversal
Greer Massey, PhD, chief scientific officer at Molecular Designs, shares insights on how labs are affected by the rule’s reversal and how they can prepare for future regulatory changes.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Mass General Brigham Launches Genetic Test for Eight Cardiovascular Conditions
The clinician-ordered test integrates polygenic risk scores validated in over 236,000 participants from the NIH's All of Us Research Program.
Equipment & Supply Spotlight
Multitiered Business Intelligence Platform for Lab Data Analytics Launches
The new platform offers three-tiered approach to help laboratories at different stages of data maturity extract actionable insights from operational data.
News, Know-How & Standards
Disease Detection & Understanding
Monod Bio Receives $1.5M Gates Foundation Grant for TB Diagnostic Development
Seattle startup will use funding to develop urine-based tuberculosis test using engineered NovoBodies technology for low-resource settings.
